Article info
Original research
Assessing data protection and governance in health information systems: a novel methodology of Privacy and Ethics Impact and Performance Assessment (PEIPA)
- Correspondence to Dr Concetta Tania Di Iorio, Legal, Serectrix, Pescara 65121, Italy; ct.diiorio{at}serectrix.eu
Citation
Assessing data protection and governance in health information systems: a novel methodology of Privacy and Ethics Impact and Performance Assessment (PEIPA)
Publication history
- Received November 8, 2019
- Revised February 14, 2020
- Accepted March 12, 2020
- First published March 27, 2020.
Online issue publication
November 29, 2021
Article Versions
- Previous version (27 March 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Privacy impact assessment in the design of transnational public health information systems: the BIRO project
- How to use relevant data for maximal benefit with minimal risk: digital health data governance to protect vulnerable populations in low-income and middle-income countries
- Navigating data governance associated with real-world data for public benefit: an overview in the UK and future considerations
- Health research and systems’ governance are at risk: should the right to data protection override health?
- Rebooting consent in the digital age: a governance framework for health data exchange
- 'It’s not something you can take in your hands'. Swiss experts’ perspectives on health data ownership: an interview-based study
- Patients’ and public views and attitudes towards the sharing of health data for research: a narrative review of the empirical evidence
- The governance of personal data for COVID-19 response: perspective from the Access to COVID-19 Tools Accelerator
- Multiple modes of data sharing can facilitate secondary use of sensitive health data for research
- China’s Personal Information Protection Law